These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 20020949)

  • 1. The Relationship Between Lipid Peroxidation and LDL Desialylation in Experimental Atherosclerosis.
    Oztürk Z; Sönmez H; Görgün FM; Ekmekçi H; Bilgen D; Ozen N; Sözer V; Altuğ T; Kökoğlu E
    Toxicol Mech Methods; 2007; 17(5):265-73. PubMed ID: 20020949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization.
    Tertov VV; Sobenin IA; Gabbasov ZA; Popov EG; Jaakkola O; Solakivi T; Nikkari T; Smirnov VN; Orekhov AN
    Lab Invest; 1992 Nov; 67(5):665-75. PubMed ID: 1434544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of desialylated low-density lipoproteins which cause intracellular lipid accumulation.
    Tertov VV; Sobenin IA; Orekhov AN
    Int J Tissue React; 1992; 14(4):155-62. PubMed ID: 1478792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sialic acid content of LDL in coronary artery disease: no evidence of desialylation in subjects with coronary stenosis and increased levels in subjects with extensive atherosclerosis and acute myocardial infarction: relation between desialylation and in vitro peroxidation.
    Chappey B; Beyssen B; Foos E; Ledru F; Guermonprez JL; Gaux JC; Myara I
    Arterioscler Thromb Vasc Biol; 1998 Jun; 18(6):876-83. PubMed ID: 9633926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship of TFPI, Lp(a), and oxidized LDL antibody levels in patients with coronary artery disease.
    Bilgen D; Sönmez H; Ekmekçi H; Ulutin T; Oztürk Z; Kökoğlu E; Bayram C; Soner A; Domaniç N
    Clin Biochem; 2005 Jan; 38(1):92-6. PubMed ID: 15607324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Desialylated low density lipoproteins--atherogenic lipoproteins occurring in blood of patients with coronary atherosclerosis].
    Mukhin DN; Tertov VV; Kacharava AG; Orekhov AN
    Biull Eksp Biol Med; 1990 Aug; 110(8):138-40. PubMed ID: 2291955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbohydrate composition of circulating multiple-modified low-density lipoprotein.
    Zakiev ER; Sobenin IA; Sukhorukov VN; Myasoedova VA; Ivanova EA; Orekhov AN
    Vasc Health Risk Manag; 2016; 12():379-385. PubMed ID: 27789955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between the electrophoretic mobility of lipoproteins and coronary heart disease.
    Kökoğlu E; Süer S; Sönmez H; Uçişik N
    Res Commun Mol Pathol Pharmacol; 1996 Jan; 91(1):109-16. PubMed ID: 8824936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible involvement of radical reactions in desialylation of LDL.
    Tanaka K; Tokumaru S; Kojo S
    FEBS Lett; 1997 Aug; 413(2):202-4. PubMed ID: 9280282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Carbohydrate composition of native and desialylated low density lipoproteins in the plasma of patients with coronary atherosclerosis].
    Tertov VV; Sobenin IA; Gevara Kh; Morrisett DD; Orekhov AN
    Kardiologiia; 1992 Sep; 32(9-10):57-61. PubMed ID: 1287315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sialic acid content of low-density lipoprotein in women with coronary artery disease.
    Lindbohm N; Gylling H; Rajaratnam RA; Miettinen TA
    J Lab Clin Med; 2000 Aug; 136(2):110-5. PubMed ID: 10945239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidation of low-density lipoprotein cholesterol following administration of poloxamer 407 to mice results from an indirect effect.
    Johnston TP; Zhou X
    J Cardiovasc Pharmacol; 2007 Apr; 49(4):246-52. PubMed ID: 17438410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein peroxidation in adult psoriatic patients.
    Offidani AM; Ferretti G; Taus M; Simonetti O; Dousset N; Valdiguie P; Curatola G; Bossi G
    Acta Derm Venereol Suppl (Stockh); 1994; 186():38-40. PubMed ID: 8073834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein B-bound lipids as a marker for evaluation of low density lipoprotein oxidation in vivo.
    Tertov VV; Kaplun VV; Dvoryantsev SN; Orekhov AN
    Biochem Biophys Res Commun; 1995 Sep; 214(2):608-13. PubMed ID: 7677772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid peroxidative damage in the erythrocytes and elevation of serum LDL-cholesterol, apolipoprotein-B, ferritin and uric acid with age and in coronary heart disease patients.
    El-Gebali HH; Tahir SA; Haider SS; El-Fakhri MM
    Saudi Med J; 2000 Feb; 21(2):184-9. PubMed ID: 11533779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of acidic sugar chains of apolipoprotein B-100 in cellular metabolism of low-density lipoproteins.
    Fujioka Y; Taniguchi T; Ishikawa Y; Yokoyama M
    J Lab Clin Med; 2000 Nov; 136(5):355-62. PubMed ID: 11079462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naturally occurring modified low density lipoproteins are similar if not identical: more electronegative and desialylated lipoprotein subfractions.
    Tertov VV; Bittolo-Bon G; Sobenin IA; Cazzolato G; Orekhov AN; Avogaro P
    Exp Mol Pathol; 1995 Jun; 62(3):166-72. PubMed ID: 8612720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of estrogen-only therapy on LDL oxidation in women with hysterectomy: does paraoxonase genotype play a role?
    Akçay YD; Sagin FG; Sendağ F; Oztekin K; Sozmen EY
    Maturitas; 2006 Feb; 53(3):325-32. PubMed ID: 16023312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of low density lipoprotein isolated from circulating immune complexes.
    Tertov VV; Sobenin IA; Orekhov AN; Jaakkola O; Solakivi T; Nikkari T
    Atherosclerosis; 1996 May; 122(2):191-9. PubMed ID: 8769682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.